Tcg Crossover Management Llc

Top Portfolio
Top Buys
Top Sells
New Buys
Exits
VistaGen Therapeutics, Inc.
VTGN
$14.13M9.92.68M0%+$00.02
Adverum Biotechnologies, Inc.
ADVM
$28.4M9.682.01MNew+$28.4M0.05
Astria Therapeutics, Inc.
ATXS
$74.3M9.615.28MNew+$74.3M0.12
Aerovate Therapeutics, Inc.
AVTE
$65.09M7.642.2M0%+$00.1
Savara Inc.
SVRA
$49.8M7.2410M0%+$00.08
Silence Therapeutics plc
SLN
$71.18M7.063.3M+56.56%+$25.71M0.11
Cogent Biosciences, Inc.
COGT
$41.76M6.56.21M+10.36%+$3.92M0.07
Mineralys Therapeutics, Inc.
MLYS
$41.12M6.423.19MNew+$41.12M0.07
Tourmaline Bio, Inc.
TRML
$33.84M5.761.48M+46.6%+$10.76M0.05
COMPASS Pathways plc
CMPS
$32.1M5.643.86M0%+$00.05
CG Oncology, Inc. Common stock
CGON
$156.73M5.363.57MNew+$156.73M0.25
AN2 Therapeutics, Inc.
ANTX
$5.05M5.211.56M-41.93%-$3.65M0.01
Tyra Biosciences, Inc.
TYRA
$32.62M3.791.99M0%+$00.05
Ocular Therapeutix, Inc.
OCUL
$48.4M3.435.32MNew+$48.4M0.08
Structure Therapeutics Inc.
GPCR
$68.51M3.431.6M-24.23%-$21.91M0.11
Geron Corporation
GERN
$57.39M2.9317.39M-25.6%-$19.75M0.09
KalVista Pharmaceuticals, Inc.
KALV
$13.8M2.761.16M-65.74%-$26.47M0.02
Dyne Therapeutics, Inc.
DYN
$75.24M2.722.65M+60.6%+$28.39M0.12
Keros Therapeutics, Inc.
KROS
$58.21M2.44879,344New+$58.21M0.09
Edgewise Therapeutics, Inc.
EWTX
$41.45M2.432.27MNew+$41.45M0.07
Nektar Therapeutics
NKTR
$3.74M2.184MNew+$3.74M0.01
Tarsus Pharmaceuticals, Inc.
TARS
$28.86M2.1793,829-30.54%-$12.69M0.05
Kura Oncology, Inc.
KURA
$30.37M1.871.42M0%+$00.05
C4 Therapeutics, Inc.
CCCC
$10.43M1.861.28M0%+$00.02
Centessa Pharmaceuticals plc
CNTA
$23.06M1.812.04M0%+$00.04
Entrada Therapeutics, Inc.
TRDA
$8.29M1.73584,9550%+$00.01
Kodiak Sciences Inc.
KOD
$4.73M1.71899,999+235.89%+$3.32M0.01
Soleno Therapeutics, Inc.
SLNO
$23.54M1.59550,000New+$23.54M0.04
Ventyx Biosciences, Inc.
VTYX
$4.49M1.16815,7240%+$00.01
Madrigal Pharmaceuticals, Inc.
MDGL
$39.86M0.7149,283-17.03%-$8.18M0.06
Cabaletta Bio, Inc.
CABA
$1.48M0.1886,795-82.17%-$6.82M<0.01
Abivax SA American Depositary Shares
ABVX
$15.73M<0.011.1M0%+$00.03
Inhibrx, Inc.
INBX
$61.19B<0.011.75M0%+$098.07